Latest Insider Transactions at Balchem Corp (BCPC)
This section provides a real-time view of insider transactions for Balchem Corp (BCPC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BALCHEM CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BALCHEM CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 08
2024
|
David B Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
540
+3.71%
|
-
|
|
Feb 08
2024
|
William A. Backus VP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,130
-7.64%
|
$161,590
$143.43 P/Share
|
|
Feb 08
2024
|
William A. Backus VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,689
+8.42%
|
-
|
|
Feb 08
2024
|
Matthew David Wineinger |
BUY
Grant, award, or other acquisition
|
Direct |
540
+6.72%
|
-
|
|
Sep 11
2023
|
David B Fischer |
SELL
Open market or private sale
|
Direct |
3,800
-22.0%
|
$497,800
$131.57 P/Share
|
|
Jul 27
2023
|
Hatsuki Miyata EVP, Gen. Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
482
-9.7%
|
$61,696
$128.54 P/Share
|
|
May 02
2023
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,300
-29.78%
|
$299,000
$130.36 P/Share
|
|
Mar 20
2023
|
David B Fischer |
SELL
Open market or private sale
|
Direct |
3,000
-14.8%
|
$381,000
$127.01 P/Share
|
|
Feb 13
2023
|
Jonathan Harrison Griffin SVP & GM, Animal Nutrition |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-1.93%
|
$27,945
$135.67 P/Share
|
|
Feb 13
2023
|
William A. Backus VP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
332
-2.7%
|
$44,820
$135.67 P/Share
|
|
Feb 13
2023
|
Theodore L Harris Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,568
-2.97%
|
$346,680
$135.67 P/Share
|
|
Feb 13
2023
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
278
-3.52%
|
$37,530
$135.67 P/Share
|
|
Feb 13
2023
|
John Y Televantos |
SELL
Payment of exercise price or tax liability
|
Direct |
258
-0.88%
|
$34,830
$135.67 P/Share
|
|
Feb 13
2023
|
Carl Martin Bengtsson EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
501
-2.99%
|
$67,635
$135.67 P/Share
|
|
Feb 13
2023
|
Michael Brent Tignor SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
297
-3.63%
|
$40,095
$135.67 P/Share
|
|
Feb 13
2023
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Payment of exercise price or tax liability
|
Direct |
264
-3.36%
|
$35,640
$135.67 P/Share
|
|
Feb 08
2023
|
Jonathan Harrison Griffin SVP & GM, Animal Nutrition |
SELL
Payment of exercise price or tax liability
|
Direct |
758
-6.6%
|
$104,604
$138.09 P/Share
|
|
Feb 08
2023
|
Jonathan Harrison Griffin SVP & GM, Animal Nutrition |
BUY
Grant, award, or other acquisition
|
Direct |
2,999
+11.91%
|
-
|
|
Feb 08
2023
|
Carl Martin Bengtsson EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,759
-9.51%
|
$242,742
$138.09 P/Share
|
|
Feb 08
2023
|
Carl Martin Bengtsson EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,992
+12.54%
|
-
|
|
Feb 08
2023
|
William A. Backus VP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,190
-8.82%
|
$164,220
$138.09 P/Share
|
|
Feb 08
2023
|
William A. Backus VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,810
+9.53%
|
-
|
|
Feb 08
2023
|
Theodore L Harris Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,864
-9.3%
|
$1,223,232
$138.09 P/Share
|
|
Feb 08
2023
|
Theodore L Harris Chairman, President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,624
+11.42%
|
-
|
|
Feb 08
2023
|
Michael Robert Sestrick SVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-11.23%
|
$137,862
$138.09 P/Share
|
|
Feb 08
2023
|
Michael Robert Sestrick SVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,743
+13.75%
|
-
|
|
Feb 08
2023
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Payment of exercise price or tax liability
|
Direct |
918
-10.45%
|
$126,684
$138.09 P/Share
|
|
Feb 08
2023
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
BUY
Grant, award, or other acquisition
|
Direct |
2,096
+10.87%
|
-
|
|
Feb 08
2023
|
Michael Brent Tignor SVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,060
-11.48%
|
$146,280
$138.09 P/Share
|
|
Feb 08
2023
|
Michael Brent Tignor SVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,649
+13.03%
|
-
|
|
Feb 08
2023
|
Frederic Boned SVP/GM, Human Nutri. & Health |
BUY
Grant, award, or other acquisition
|
Direct |
770
+16.88%
|
-
|
|
Feb 08
2023
|
Hatsuki Miyata EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
770
+13.73%
|
-
|
|
Feb 08
2023
|
Martin Luther Reid SVP Chief Supply Chain Officer |
BUY
Grant, award, or other acquisition
|
Direct |
810
+15.98%
|
-
|
|
Feb 08
2023
|
David B Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
530
+2.55%
|
-
|
|
Feb 08
2023
|
Daniel E Knutson |
BUY
Grant, award, or other acquisition
|
Direct |
530
+10.52%
|
-
|
|
Feb 08
2023
|
Kathleen B Fish |
BUY
Grant, award, or other acquisition
|
Direct |
530
+33.78%
|
-
|
|
Feb 08
2023
|
Joyce J. Lee |
BUY
Grant, award, or other acquisition
|
Direct |
530
+19.16%
|
-
|
|
Feb 08
2023
|
John Y Televantos |
BUY
Grant, award, or other acquisition
|
Direct |
530
+1.77%
|
-
|
|
Feb 08
2023
|
Perry W Premdas |
BUY
Grant, award, or other acquisition
|
Direct |
530
+1.03%
|
-
|
|
Feb 08
2023
|
Matthew David Wineinger |
BUY
Grant, award, or other acquisition
|
Direct |
530
+7.08%
|
-
|
|
Aug 12
2022
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Open market or private sale
|
Direct |
1,000
-41.15%
|
$131,000
$131.12 P/Share
|
|
Aug 12
2022
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+29.15%
|
$58,000
$58.52 P/Share
|
|
Aug 05
2022
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Open market or private sale
|
Direct |
2,629
-64.77%
|
$333,883
$127.01 P/Share
|
|
Aug 05
2022
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
BUY
Exercise of conversion of derivative security
|
Direct |
2,629
+39.31%
|
$131,450
$50.32 P/Share
|
|
Aug 04
2022
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Open market or private sale
|
Direct |
1,371
-48.95%
|
$174,117
$127.0 P/Share
|
|
Aug 04
2022
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
BUY
Exercise of conversion of derivative security
|
Direct |
1,371
+32.86%
|
$68,550
$50.32 P/Share
|
|
Aug 03
2022
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
SELL
Open market or private sale
|
Direct |
3,601
-46.61%
|
$450,125
$125.51 P/Share
|
|
Aug 03
2022
|
Job Leonard Van Gunsteren SVP and GM, Specialty Products |
BUY
Exercise of conversion of derivative security
|
Direct |
2,200
+19.76%
|
$105,600
$48.31 P/Share
|
|
Apr 01
2022
|
William A. Backus VP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
750
+6.58%
|
-
|
|
Feb 15
2022
|
John Y Televantos |
SELL
Payment of exercise price or tax liability
|
Direct |
359
-1.23%
|
$49,901
$139.38 P/Share
|